ARCHIVES

Phase III Trial: Panobinostat Increases PFS by Four Months

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

House Committee Investigates FDA Commissioner; False and Misleading Testimony Alleged.

April 6, 2007

NCAB Approves Characteristics for Recognition As Comprehensive; Outlook Dim for New Division

May 19, 1989

Funding Opportunities

September 6, 2002

Rituximab After CVP Improves Progression-Free Survival

March 27, 2009

Senate Outlines Budget Priorities In Bill Report

July 19, 1991

Informatics: Gore Helps NCI Open CGAP Website

August 8, 1997